Why is Kwality Pharma falling/rising?

As of 19-Sep, Kwality Pharmaceuticals Ltd is currently priced at 957.85, reflecting a decline of 28.85 points or 2.92%. The stock has underperformed its sector by 3.19% today and has experienced a trend reversal, falling after two consecutive days of gains. It touched an intraday low of Rs 952.35, indicating a significant drop of 3.48%. Over the past week, the stock has decreased by 3.06%, and in the last month, it has fallen by 9.93%. Despite these short-term declines, the stock has shown strong performance over the longer term, with a year-to-date increase of 10.15% and a one-year return of 23.73%. The company has demonstrated a strong ability to service its debt, evidenced by a low Debt to EBITDA ratio of 1.03 times, and has reported positive results for six consecutive quarters, contributing to its attractive valuation.
In the broader market context, while the stock has faced recent declines, it has outperformed the benchmark index, Sensex, which has shown a slight increase of 0.88% over the past week. The stock's performance is notable given that the broader market (BSE500) has generated negative returns of -1.96% in the last year, while Kwality Pharmaceuticals has achieved a return of 23.73%. However, the recent drop in investor participation, with delivery volume falling by 42.74% against the five-day average, suggests a decrease in market confidence. Additionally, the stock is trading below its shorter-term moving averages, which may indicate bearish sentiment among investors despite its strong long-term fundamentals.